120
Participants
Start Date
May 31, 2025
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2028
Bupivicaine intervention arm
TAP blocks in intervention group will include 0.5% bupivacaine in 30mL solution of 15mL normal saline and 15mL bupivacaine
Placebo arm
Placebo group TAP block syringe will include 30mL normal saline
Regional One Health
OTHER
University of Tennessee
OTHER